OTC nicotine replacement therapy used in 5.8 mil. quit attempts a year -- SmithKline study.
This article was originally published in The Tan Sheet
Executive Summary
OTC NICOTINE REPLACEMENT THERAPY PART OF 5.8 MIL. 1997 QUIT ATTEMPTS in the U.S., according to estimates in study by Saul Shiffman, PhD, University of Pittsburgh, and SmithKline Beecham researchers published in the most recent issue of Tobacco Control, an independent quarterly journal. The estimate is based on extrapolation of A.C. Nielsen data from March through May 1997 showing 112,000 new purchases per week of SmithKline's Nicorette gum and NicoDerm CQ patch and McNeil Consumer Products' Nicotrol patch.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning